Literature DB >> 22615164

Comparative cellular and molecular analyses of pooled bone marrow multipotent mesenchymal stromal cells during continuous passaging and after successive cryopreservation.

Murali Krishna Mamidi1, Kavitha Ganesan Nathan, Gurbind Singh, Saratha Thevi Thrichelvam, Nurul Ain Nasim Mohd Yusof, Noor Atiqah Fakharuzi, Zubaidah Zakaria, Ramesh Bhonde, Anjan Kumar Das, Anish Sen Majumdar.   

Abstract

The clinical application of human bone marrow derived multipotent mesenchymal stromal cells (MSC) requires expansion, cryopreservation, and transportation from the laboratory to the site of cell implantation. The cryopreservation and thawing process of MSCs may have important effects on the viability, growth characteristics and functionality of these cells both in vitro and in vivo. More importantly, MSCs after two rounds of cryopreservation have not been as well characterized as fresh MSCs from the transplantation perspective. The objective of this study was to determine if the effect of successive cryopreservation of pooled MSCs during the exponential growth phase could impair their morphology, phenotype, gene expression, and differentiation capabilities. MSCs cryopreserved at passage 3 (cell bank) were thawed and expanded up to passage 4 and cryopreserved for the second time. These cells (passive) were then thawed and cultured up to passage 6, and, at each passage MSCs were characterized. As control, pooled passage 3 cells (active) after one round of cryopreservation were taken all the way to passage 6 without cryopreservation. We determined the growth rate of MSCs for both culture conditions in terms of population doubling number (PDN) and population doubling time (PDT). Gene expression profiles for pluripotency markers and tissue specific markers corresponding to neuroectoderm, mesoderm and endoderm lineages were also analyzed for active and passive cultures of MSC. The results show that in both culture conditions, MSCs exhibited similar growth properties, phenotypes and gene expression patterns as well as similar differentiation potential to osteo-, chondro-, and adipo-lineages in vitro. To conclude, it appears that successive or multiple rounds of cryopreservation of MSCs did not alter the fundamental characteristics of these cells and may be used for clinical therapy.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22615164     DOI: 10.1002/jcb.24193

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  33 in total

1.  Clinical mesenchymal stromal cell products undergo functional changes in response to freezing.

Authors:  Kathryn Pollock; Darin Sumstad; Diane Kadidlo; David H McKenna; Allison Hubel
Journal:  Cytotherapy       Date:  2014-10-24       Impact factor: 5.414

2.  Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review.

Authors:  Ioannis Christodoulou; Maria Goulielmaki; Marina Devetzi; Mihalis Panagiotidis; Georgios Koliakos; Vassilis Zoumpourlis
Journal:  Stem Cell Res Ther       Date:  2018-12-07       Impact factor: 6.832

3.  Cardiac stem cells: translation to human studies.

Authors:  Zijun Ge; Sean Lal; Thi Y L Le; Cris Dos Remedios; James J H Chong
Journal:  Biophys Rev       Date:  2014-12-03

Review 4.  In vitro and in vivo neurogenic potential of mesenchymal stem cells isolated from different sources.

Authors:  Ramyani Taran; Murali Krishna Mamidi; Gurbind Singh; Susmita Dutta; Ishwar S Parhar; John P John; Ramesh Bhonde; Rajarshi Pal; Anjan Kumar Das
Journal:  J Biosci       Date:  2014-03       Impact factor: 1.826

Review 5.  Mesenchymal stromal cells in hematopoietic cell transplantation.

Authors:  Andre J Burnham; Lisa P Daley-Bauer; Edwin M Horwitz
Journal:  Blood Adv       Date:  2020-11-24

6.  Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease: a multicenter survey.

Authors:  Zyrafete Kuçi; Halvard Bönig; Hermann Kreyenberg; Milica Bunos; Anna Jauch; Johannes W G Janssen; Marijana Škifić; Kristina Michel; Ben Eising; Giovanna Lucchini; Shahrzad Bakhtiar; Johann Greil; Peter Lang; Oliver Basu; Irene von Luettichau; Ansgar Schulz; Karl-Walter Sykora; Andrea Jarisch; Jan Soerensen; Emilia Salzmann-Manrique; Erhard Seifried; Thomas Klingebiel; Peter Bader; Selim Kuçi
Journal:  Haematologica       Date:  2016-05-12       Impact factor: 9.941

7.  Sequential cultivation of human epidermal keratinocytes and dermal mesenchymal like stromal cells in vitro.

Authors:  Shyam Mahabal; Vijay Bhaskar Reddy Konala; Murali Krishna Mamidi; Mohammad Mahboob Kanafi; Suniti Mishra; Krupa Shankar; Rajarshi Pal; Ramesh Bhonde
Journal:  Cytotechnology       Date:  2015-02-20       Impact factor: 2.058

8.  Improved Post-Thaw Function and Epigenetic Changes in Mesenchymal Stromal Cells Cryopreserved Using Multicomponent Osmolyte Solutions.

Authors:  Kathryn Pollock; Rebekah M Samsonraj; Amel Dudakovic; Roman Thaler; Aron Stumbras; David H McKenna; Peter I Dosa; Andre J van Wijnen; Allison Hubel
Journal:  Stem Cells Dev       Date:  2017-03-15       Impact factor: 3.272

9.  Secretome studies of mesenchymal stromal cells (MSCs) isolated from three tissue sources reveal subtle differences in potency.

Authors:  Vijay Bhaskar Reddy Konala; Ramesh Bhonde; Rajarshi Pal
Journal:  In Vitro Cell Dev Biol Anim       Date:  2020-10-02       Impact factor: 2.416

Review 10.  Genetically engineered mesenchymal stem cells: targeted delivery of immunomodulatory agents for tumor eradication.

Authors:  Meysam Mosallaei; Miganoosh Simonian; Naeim Ehtesham; Mohammad Reza Karimzadeh; Nasim Vatandoost; Babak Negahdari; Rasoul Salehi
Journal:  Cancer Gene Ther       Date:  2020-05-18       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.